The Nottingham Staphylococcus aureus population study:: prevalence of MRSA among the elderly in a university hospital

被引:57
作者
Hori, S [1 ]
Sunley, R [1 ]
Tami, A [1 ]
Grundmann, H [1 ]
机构
[1] Univ Nottingham Hosp, Queens Med Ctr, Div Microbiol & Infect Dis, Nottingham NG7 2UH, England
关键词
MRSA; prevalence; cross-sectional study; risk factors; nosocomial acquisition; antibiotic exposure; ciprofloxacin; discharge destination;
D O I
10.1053/jhin.2001.1130
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A prevalence survey of methicillin-resistant Staphylococcus aureus (MRSA) in elderly patients (65 years and older) three weeks after admission to a university hospital was performed. Risk factors associated with hospital MRSA carriage were determined. The design was a cross-sectional patient-based study and all adult wards at the University Hospital Nottingham (1600 beds) were included. Three hundred and forty-two elderly individuals (65 years and older) were enrolled into the study on day 21 after admission. One hundred and twenty patients [35.08% (95% confidence intervals 29.93-40.25%)] carried S. aureus. MRSA was isolated from 54 patients. The MRSA prevalence was 158/1000 (95% CI 119-197/1000 patients). Independent risk factors for MRSA carriage in the hospital were exposure to ampicillin [adjusted odds ratio 4.1 (95% CI 1.28-13.14)] and ciprofloxacin [17.1 (95% CI 2.91-99.90)]. Forty-one MRSA isolates (75.9%) belonged to the epidemic type EMRSA 15, seven isolates to EMRSA 16 (12.9%) and six isolates were sporadic strains as determined by genetic typing. It can be expected that among this defined risk group, between 187 and 331 patients carried MRSA on discharge in the year 2000. MRSA carriage is frequent and detected in only 15% of actual carriers amongst elderly patients by routine clinical investigations three weeks after admission. The only significant risk factor identified by multivariate logistic regression was antibiotic chemotherapy. The repeated finding of a strong association between MRSA colonization and previous ciprofloxacin exposure demands attention and indicates that fluoroquinolones should be used prudently in institutions where MRSA is endemic. (C) 2002 The Hospital Infection Society.
引用
收藏
页码:25 / 29
页数:5
相关论文
共 20 条
[1]   RAPID DEVELOPMENT OF CIPROFLOXACIN RESISTANCE IN METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
BLUMBERG, HM ;
RIMLAND, D ;
CARROLL, DJ ;
TERRY, P ;
WACHSMUTH, IK .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1279-1285
[2]   PROSPECTIVE-STUDY OF INFECTION, COLONIZATION AND CARRIAGE OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS IN AN OUTBREAK AFFECTING 990 PATIENTS [J].
COELLO, R ;
JIMENEZ, J ;
GARCIA, M ;
ARROYO, P ;
MINGUEZ, D ;
FERNANDEZ, C ;
CRUZET, F ;
GASPAR, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (01) :74-81
[3]   Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals [J].
Crowcroft, NS ;
Ronveaux, O ;
Monnet, DL ;
Mertens, R .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (01) :31-36
[4]   Methicillin-resistant Staphylococcus aureus in a teaching hospital:: investigation of nosocomial transmission using a matched case-control study [J].
Dziekan, G ;
Hahn, A ;
Thüne, K ;
Schwarzer, G ;
Schäfer, K ;
Daschner, FD ;
Grundmann, H .
JOURNAL OF HOSPITAL INFECTION, 2000, 46 (04) :263-270
[5]  
GRUNDMANN H, 2001, IN PRESS BR MED J
[6]  
*HOUS LORDS, 1998, RES ANT OTH ANT AG
[7]   Evaluation of the mecA femB duplex polymerase chain reaction for detection of methicillin-resistant Staphylococcus aureus [J].
Jonas, D ;
Grundmann, H ;
Hartung, D ;
Daschner, FD ;
Towner, KJ .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (09) :643-647
[8]  
Jones EM, 1997, LANCET, V349, P1176, DOI 10.1016/S0140-6736(05)63056-5
[9]   Outbreaks of Staphylococcus aureus infections during treatment of late onset pneumonia with ciprofloxacin in a prospective, randomized study [J].
Manhold, C ;
von Rolbicki, U ;
Brase, R ;
Timm, J ;
von Pritzbuer, E ;
Heimesaat, M ;
Kljucar, S .
INTENSIVE CARE MEDICINE, 1998, 24 (12) :1327-1330
[10]  
Monnet DL, 1998, INFECT CONT HOSP EP, V19, P552